|
(n= 202) |
(n=43) |
(n=159) |
|
Age, y |
72.2 ± 13.4 |
55.4 ± 11.7 |
76.8 ± 9.7 |
<0.0001 |
Male, n (%) |
127 (62%) |
31 (72%) |
96 (62%) |
0.15 |
Hypertension, n (%) |
153 (75%) |
20 (47%) |
133 (83%) |
<0.0001 |
Diabetes mellitus, n (%) |
35 (17%) |
3 (7%) |
32 (20%) |
0.16 |
Smoking, n (%) |
21 (10%) |
7 (16%) |
14 (8.8%) |
0.43 |
Dyslipidemia (%) |
121 (60%) |
20 (47%) |
101 (63%) |
0.13 |
Chronic Kidney disease (%) |
11 (5%) |
1 (2%) |
10 (6%) |
0.5 |
Statin therapy (%) |
116 (57%) |
18 (42%) |
98 (62%) |
0.05 |
Obstructive Perypheral vascular disease (%) |
31 (15%) |
1 (2%) |
30
(19%) |
0.01 |
Abdominal aortic aneurysm (%) |
7 (3%) |
1 (2%) |
6 (4%) |
0.5 |
CAD (%) |
49 (24%) |
3 (7%) |
46 (29%) |
0.01 |
Body Surface Area - Dubois (m2) |
1.91 ± 0.25 |
1.97 ±
0.24 |
1.89 ± 0.25 |
0.06 |
SBP (mmHg) |
126.6 ± 13.9 |
125.4 ± 11.7 |
126.7 ± 14.4 |
0.60 |
DBP (mmHg) |
77.7 ± 7.8 |
78.1 ± 8.4 |
77.3 ± 7.7 |
0.59 |
Doppler echocardiography data |
|
|
|
|
Baseline LVEF, % |
61.3 ± 9.0 |
65.0 ± 7.5 |
60.4 ± 9.3 |
0.003 |
Baseline end diastolic left ventricle diameter (cm) |
4.8 ± 0.6 |
5.0 ±
0.7 |
4.8 ± 0.6 |
0.11 |
Baseline end systolic left ventricle diameter (cm) |
2.9 ± 0.6 |
3.0 ±
0.7 |
2.9 ± 0.6 |
0.64 |
Baseline Vmax (m/s) |
2.9 ± 0.8 |
3.1 ± 0.9 |
2.9 ± 0.7 |
0.03 |
Baseline Maximum gradient (mmHg) |
36.9 ± 21.2 |
42.7 ± 24.9 |
35.4 ±
20.7 |
0.02 |
Baseline MG (mmHg) |
22.8 ± 13.4 |
27.0 ± 16.5 |
21.7 ± 12.3 |
0.05 |
Baseline AVA (cm2) |
1.2 ± 0.3 |
1.2 ± 0.3 |
1.2 ± 0.3 |
0.80 |
Baseline AVAi (cm2/m2) |
0.6 ± 0.2 |
0.6 ± 0.2 |
0.6 ± 0.2 |
0.64 |
Baseline Dimensionless index |
0.3 ± 0.1 |
0.3 ± 0.1 |
0.3 ± 0.1 |
0.31 |
Baseline AS haemodynamic severity |
|
|
|
|
Mild AS n (%)
|
90 (44%)
|
18 (42%)
|
72 (45%)
|
0.68
|
Moderate AS n (%)
|
52 (26%)
|
11 (26%)
|
41 (26%)
|
0.97
|
Severe AS n (%)
|
60 (30%)
|
14 (32%)
|
46 (29%)
|
0.86
|